Ubiquitin-Conjugating Enzyme E2 Variant 1 (UBE2V1) (C-Term) Peptide
UBE2V1
Reactivity: Human
BP
Sodium azide
-
- Target See all UBE2V1 products
- UBE2V1 (Ubiquitin-Conjugating Enzyme E2 Variant 1 (UBE2V1))
- Protein Region
- C-Term
- Origin
- Human
- Application
- Blocking Peptide (BP)
- Characteristics
-
15 amino acids near the carboxy terminus of human UEV1A.
Human
-
-
- Application Notes
- UEV1A peptide is used for blocking the activity of UEV1A.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Expiry Date
- 12 months
-
- Target
- UBE2V1 (Ubiquitin-Conjugating Enzyme E2 Variant 1 (UBE2V1))
- Synonyms
- CIR1 Peptide, CROC-1 Peptide, CROC1 Peptide, UBE2V Peptide, UEV-1 Peptide, UEV1 Peptide, UEV1A Peptide, 0610011J09Rik Peptide, AI256840 Peptide, D7Bwg1382e Peptide, CROC-1B Peptide, ubiquitin conjugating enzyme E2 V1 Peptide, ubiquitin-conjugating enzyme E2 variant 1 Peptide, UBE2V1 Peptide, ube2v1 Peptide, Ube2v1 Peptide
-
You are here:
